Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur M Feldman

Showing results (181-190 of 224) with videos related to

Pageof 23
Sort By:
Cells|March 29, 2023
BAG3: Nature's Quintessential Multi-Functional Protein Functions as a Ubiquitous Intra-Cellular GlueCaitlyn M Brenner, Muaaz Choudhary, Michael G McCormick, et al.
Journal of Cardiac Failure|March 31, 2009
Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trialDennis M McNamara, S William Tam, Michael L Sabolinski, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 28, 2024
Rare variants in cardiomyopathy genes predispose to cardiac injury in severe COVID-19 patients of African or Hispanic ancestryHui-Qi Qu, Matthew S Delfiner, Chethan Gangireddy, et al.
Circulation|July 13, 2011
Controlled and cardiac-restricted overexpression of the arginine vasopressin V1A receptor causes reversible left ventricular dysfunction through Gαq-mediated cell signalingXue Li, Tung O Chan, Valerie Myers, et al.
Circulation Research|December 20, 2011
Gi-biased β2AR signaling links GRK2 upregulation to heart failureWeizhong Zhu, Natalia Petrashevskaya, Shuxun Ren, et al.
Journal of the American College of Cardiology|December 20, 2005
Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trialArthur M Feldman, Gregory de Lissovoy, Michael R Bristow, et al.
Circulation|December 28, 2006
Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failureJoAnn Lindenfeld, Arthur M Feldman, Leslie Saxon, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 21, 2007
The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trialEric J Velazquez, Kerry L Lee, Christopher M O'Connor, et al.
Circulation|March 28, 2009
2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung TransplantationMariell Jessup, William T Abraham, Donald E Casey, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 11, 2015
Ca²⁺ entry via Trpm2 is essential for cardiac myocyte bioenergetics maintenanceNicholas E Hoffman, Barbara A Miller, JuFang Wang, et al.
Pageof 23

Showing results (181-190 of 224) with videos related to

Sort By:
Pageof 23
Cells|March 29, 2023
BAG3: Nature's Quintessential Multi-Functional Protein Functions as a Ubiquitous Intra-Cellular GlueCaitlyn M Brenner, Muaaz Choudhary, Michael G McCormick, et al.
Journal of Cardiac Failure|March 31, 2009
Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trialDennis M McNamara, S William Tam, Michael L Sabolinski, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 28, 2024
Rare variants in cardiomyopathy genes predispose to cardiac injury in severe COVID-19 patients of African or Hispanic ancestryHui-Qi Qu, Matthew S Delfiner, Chethan Gangireddy, et al.
Circulation|July 13, 2011
Controlled and cardiac-restricted overexpression of the arginine vasopressin V1A receptor causes reversible left ventricular dysfunction through Gαq-mediated cell signalingXue Li, Tung O Chan, Valerie Myers, et al.
Circulation Research|December 20, 2011
Gi-biased β2AR signaling links GRK2 upregulation to heart failureWeizhong Zhu, Natalia Petrashevskaya, Shuxun Ren, et al.
Journal of the American College of Cardiology|December 20, 2005
Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trialArthur M Feldman, Gregory de Lissovoy, Michael R Bristow, et al.
Circulation|December 28, 2006
Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failureJoAnn Lindenfeld, Arthur M Feldman, Leslie Saxon, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 21, 2007
The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trialEric J Velazquez, Kerry L Lee, Christopher M O'Connor, et al.
Circulation|March 28, 2009
2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung TransplantationMariell Jessup, William T Abraham, Donald E Casey, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 11, 2015
Ca²⁺ entry via Trpm2 is essential for cardiac myocyte bioenergetics maintenanceNicholas E Hoffman, Barbara A Miller, JuFang Wang, et al.
Pageof 23